Welcome to Markets Desk, your midday read on what's moving markets and the broader economy.
The so-called debasement trade appears to be losing its grip on investor imagination. Outflows from both gold and bitcoin ETFs signal that the thesis built around currency erosion and fiscal recklessness is fading, at least for now. Whether that reflects genuine macro confidence or simple rotation remains the open question on the floor.
Shifting to regulatory news with real market consequence, Ironwood Pharmaceuticals scored an FDA approval to expand LINZESS use to patients as young as two years old for functional constipation. That label expansion opens a pediatric market the company hadn't previously touched, and for a mid-cap biotech, new addressable population is the kind of catalyst that moves the needle on forward revenue assumptions.
And in a story that puts prediction markets squarely in the crosshairs of federal prosecutors, the Department of Justice has charged a Google software engineer with making one point two million dollars through insider trading on Polymarket. Michele Spagnuolo allegedly leveraged confidential information to place trades, facing wire fraud and money laundering charges. It's a sharp reminder that prediction markets, however novel, are not beyond the reach of commodity law enforcement, and lawmakers are already circling.
That's the tape. Markets Desk, signing off the floor.
